rdf:type |
|
lifeskim:mentions |
umls-concept:C0001792,
umls-concept:C0010181,
umls-concept:C0023779,
umls-concept:C0030705,
umls-concept:C0085542,
umls-concept:C0087111,
umls-concept:C0205156,
umls-concept:C0439234,
umls-concept:C0948089,
umls-concept:C1274040,
umls-concept:C1707455,
umls-concept:C2603343
|
pubmed:issue |
6
|
pubmed:dateCreated |
2006-6-19
|
pubmed:abstractText |
We compared cost-effectiveness of pravastatin in a placebo-controlled trial in 5500 younger (31-64 years) and 3514 older patients (65-74 years) with previous acute coronary syndromes.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1097-6744
|
pubmed:author |
pubmed-author:DentonMaryM,
pubmed-author:EckermannSimonS,
pubmed-author:FriedlanderDenisD,
pubmed-author:GlasziouPaulP,
pubmed-author:HuntDavidD,
pubmed-author:KirbyAdrienneA,
pubmed-author:LIPID Study Group,
pubmed-author:MagnusPaulP,
pubmed-author:MulraySarahS,
pubmed-author:SallabergerMicheleM,
pubmed-author:SimesJohnJ,
pubmed-author:TonkinAndrew MAM,
pubmed-author:WhiteHarveyH
|
pubmed:issnType |
Electronic
|
pubmed:volume |
151
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1305-12
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16781242-Acute Disease,
pubmed-meshheading:16781242-Adult,
pubmed-meshheading:16781242-Age Factors,
pubmed-meshheading:16781242-Aged,
pubmed-meshheading:16781242-Angina, Unstable,
pubmed-meshheading:16781242-Anticholesteremic Agents,
pubmed-meshheading:16781242-Cost-Benefit Analysis,
pubmed-meshheading:16781242-Female,
pubmed-meshheading:16781242-Hospitalization,
pubmed-meshheading:16781242-Humans,
pubmed-meshheading:16781242-Male,
pubmed-meshheading:16781242-Middle Aged,
pubmed-meshheading:16781242-Myocardial Infarction,
pubmed-meshheading:16781242-Pravastatin,
pubmed-meshheading:16781242-Survival Rate,
pubmed-meshheading:16781242-Syndrome
|
pubmed:year |
2006
|
pubmed:articleTitle |
Cost-effectiveness of cholesterol-lowering therapy with pravastatin in patients with previous acute coronary syndromes aged 65 to 74 years compared with younger patients: results from the LIPID study.
|
pubmed:affiliation |
NHMRC Centre of Clinical Research Excellence in Therapeutics, Department of Epidemiology and Preventive Medicine, Monash University, Victoria, Australia. andrew.tonkin@heartfoundation.com.au
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Controlled Clinical Trial
|